Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effect of temozolomide in patients with progressive or
recurrent stage IV non-small cell lung cancer, with or without brain metastases, who have not
been treated for metastatic disease with chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC